| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


§


From the Departments of Anatomy and Cell Biology,*
University of Iowa Cancer Center,
and the
Departments of Ophthalmology and Visual
Sciences
and
Pathology,§
University of Iowa College of
Medicine, Iowa City, Iowa; the Department of
Ophthalmology,¶
Hadassah University Hospital,
Jerusalem, Israel; and the Cancer Genetics Branch, National Human
Genome Research Institute, National Institutes of Health,
Bethesda, Maryland||
Tissue sections from aggressive human intraocular (uveal) and metastatic cutaneous melanomas generally lack evidence of significant necrosis and contain patterned networks of interconnected loops of extracellular matrix. The matrix that forms these loops or networks may be solid or hollow. Red blood cells have been detected within the hollow channel components of this patterned matrix histologically, and these vascular channel networks have been detected in human tumors angiographically. Endothelial cells were not identified within these matrix-embedded channels by light microscopy, by transmission electron microscopy, or by using an immunohistochemical panel of endothelial cell markers (Factor VIII-related antigen, Ulex, CD31, CD34, and KDR[Flk-1]). Highly invasive primary and metastatic human melanoma cells formed patterned solid and hollow matrix channels (seen in tissue sections of aggressive primary and metastatic human melanomas) in three-dimensional cultures containing Matrigel or dilute Type I collagen, without endothelial cells or fibroblasts. These tumor cell-generated patterned channels conducted dye, highlighting looping patterns visualized angiographically in human tumors. Neither normal melanocytes nor poorly invasive melanoma cells generated these patterned channels in vitro under identical culture conditions, even after the addition of conditioned medium from metastatic pattern-forming melanoma cells, soluble growth factors, or regimes of hypoxia. Highly invasive and metastatic human melanoma cells, but not poorly invasive melanoma cells, contracted and remodeled floating hydrated gels, providing a biomechanical explanation for the generation of microvessels in vitro. cDNA microarray analysis of highly invasive versus poorly invasive melanoma tumor cells confirmed a genetic reversion to a pluripotent embryonic-like genotype in the highly aggressive melanoma cells. These observations strongly suggest that aggressive melanoma cells may generate vascular channels that facilitate tumor perfusion independent of tumor angiogenesis.
This article has been cited by other articles:
![]() |
C. C. Pinnix, J. T. Lee, Z.-J. Liu, R. McDaid, K. Balint, L. J. Beverly, P. A. Brafford, M. Xiao, B. Himes, S. E. Zabierowski, et al. Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes Cancer Res., July 1, 2009; 69(13): 5312 - 5320. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. DANG and D. M. RAMOS Identification of {alpha}v{beta}6-Positive Stem Cells in Oral Squamous Cell Carcinoma Anticancer Res, June 1, 2009; 29(6): 2043 - 2049. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cedervall, S. Jamil, L. Prasmickaite, Y. Cheng, M. Eskandarpour, J. Hansson, G. M. Maelandsmo, U. Ringborg, M. Gulyas, H. S. Zhen, et al. Species-Specific In vivo Engraftment of the Human BL Melanoma Cell Line Results in an Invasive Dedifferentiated Phenotype Not Present in Xenografts Cancer Res., May 1, 2009; 69(9): 3746 - 3754. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T.-F. Shih, H.-A. Hou, C.-Y. Liu, B.-B. Chen, J.-L. Tang, H.-Y. Chen, S.-Y. Wei, M. Yao, S.-Y. Huang, W.-C. Chou, et al. Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival Blood, April 2, 2009; 113(14): 3161 - 3167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Lissitzky, D. Parriaux, E. Ristorcelli, A. Verine, D. Lombardo, and P. Verrando Cyclic AMP Signaling as a Mediator of Vasculogenic Mimicry in Aggressive Human Melanoma Cells In vitro Cancer Res., February 1, 2009; 69(3): 802 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Mourad-Zeidan, V. O. Melnikova, H. Wang, A. Raz, and M. Bar-Eli Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry Am. J. Pathol., December 1, 2008; 173(6): 1839 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Folberg, S. S. Kadkol, S. Frenkel, K. Valyi-Nagy, M. J. Jager, J. Pe'er, and A. J. Maniotis Authenticating Cell Lines in Ophthalmic Research Laboratories Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4697 - 4701. [Full Text] [PDF] |
||||
![]() |
Q. Shu, K. K. Wong, J. M. Su, A. M. Adesina, L. T. Yu, Y. T. M. Tsang, B. C. Antalffy, P. Baxter, L. Perlaky, J. Yang, et al. Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma Stem Cells, June 1, 2008; 26(6): 1414 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. van Ginkel, S. R. Darjatmoko, D. Sareen, L. Subramanian, S. Bhattacharya, M. J. Lindstrom, D. M. Albert, and A. S. Polans Resveratrol Inhibits Uveal Melanoma Tumor Growth via Early Mitochondrial Dysfunction Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1299 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bakalian, J.-C. Marshall, P. Logan, D. Faingold, S. Maloney, S. Di Cesare, C. Martins, B. F. Fernandes, and M. N. Burnier Jr. Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma Clin. Cancer Res., February 15, 2008; 14(4): 951 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fosslien Cancer Morphogenesis: Role of Mitochondrial Failure Ann. Clin. Lab. Sci., January 1, 2008; 38(4): 307 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, S. Zhang, D. Zhang, X. Yin, S. Wang, Y. Gu, and Y. Wang Doxycycline Influences Microcirculation Patterns in B16 Melanoma Experimental Biology and Medicine, November 1, 2007; 232(10): 1300 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Papadopulos-Eleopulos, B. A. P. Page, D. Causer, V. F. Turner, J. M. Papadimitriou, and A. Maniotis Cancer and Epigenetic Reversion The Fundamental Role of Redox Am. J. Pathol., November 1, 2007; 171(5): 1726 - 1727. [Full Text] [PDF] |
||||
![]() |
L. W. Horton, Y. Yu, S. Zaja-Milatovic, R. M. Strieter, and A. Richmond Opposing Roles of Murine Duffy Antigen Receptor for Chemokine and Murine CXC Chemokine Receptor-2 Receptors in Murine Melanoma Tumor Growth Cancer Res., October 15, 2007; 67(20): 9791 - 9799. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Barak, S. Frenkel, K. Valyi-Nagy, L. Leach, M. A. Apushkin, A. Y. Lin, I. Kalickman, N. A. Baumann, J. Pe'er, A. J. Maniotis, et al. Using the Direct-Injection Model of Early Uveal Melanoma Hepatic Metastasis to Identify TPS as a Potentially Useful Serum Biomarker Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4399 - 4402. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, M. F. Bolontrade, K. Reddy, X. Duan, H. Guan, L. Yu, D. J. Hicklin, and E. S. Kleinerman Suppression of Ewing's Sarcoma Tumor Growth, Tumor Vessel Formation, and Vasculogenesis Following Anti Vascular Endothelial Growth Factor Receptor-2 Therapy Clin. Cancer Res., August 15, 2007; 13(16): 4867 - 4873. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Martin and R. Schilder Novel Approaches in Advancing the Treatment of Epithelial Ovarian Cancer: The Role of Angiogenesis Inhibition J. Clin. Oncol., July 10, 2007; 25(20): 2894 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Folberg, L. Leach, K. Valyi-Nagy, A. Y. Lin, M. A. Apushkin, Z. Ai, V. Barak, D. Majumdar, J. Pe'er, and A. J. Maniotis Modeling the Behavior of Uveal Melanoma in the Liver Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 2967 - 2974. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meir, M. Zeschnigk, L. Masshofer, J. Pe'er, and I. Chowers The Spatial Distribution of Monosomy 3 and Network Vasculogenic Mimicry Patterns in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1918 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Robertson Mig-7 Linked to Vasculogenic Mimicry Am. J. Pathol., May 1, 2007; 170(5): 1454 - 1456. [Full Text] [PDF] |
||||
![]() |
A. Pezzolo, F. Parodi, M. V. Corrias, R. Cinti, C. Gambini, and V. Pistoia Tumor Origin of Endothelial Cells in Human Neuroblastoma J. Clin. Oncol., February 1, 2007; 25(4): 376 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dome, M. J.C. Hendrix, S. Paku, J. Tovari, and J. Timar Alternative Vascularization Mechanisms in Cancer: Pathology and Therapeutic Implications Am. J. Pathol., January 1, 2007; 170(1): 1 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bruno, B. Bussolati, C. Grange, F. Collino, M. E. Graziano, U. Ferrando, and G. Camussi CD133+ Renal Progenitor Cells Contribute to Tumor Angiogenesis Am. J. Pathol., December 1, 2006; 169(6): 2223 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Heidemann, D G Binion, W Domschke, and T Kucharzik Antiangiogenic therapy in human gastrointestinal malignancies. Gut, October 1, 2006; 55(10): 1497 - 1511. [Full Text] [PDF] |
||||
![]() |
R. Folberg, Z. Arbieva, J. Moses, A. Hayee, T. Sandal, S. Kadkol, A. Y. Lin, K. Valyi-Nagy, S. Setty, L. Leach, et al. Tumor Cell Plasticity in Uveal Melanoma: Microenvironment Directed Dampening of the Invasive and Metastatic Genotype and Phenotype Accompanies the Generation of Vasculogenic Mimicry Patterns Am. J. Pathol., October 1, 2006; 169(4): 1376 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Onken, J. P. Ehlers, L. A. Worley, J. Makita, Y. Yokota, and J. W. Harbour Functional Gene Expression Analysis Uncovers Phenotypic Switch in Aggressive Uveal Melanomas. Cancer Res., May 1, 2006; 66(9): 4602 - 4609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tzukerman, T. Rosenberg, I. Reiter, S. Ben-Eliezer, G. Denkberg, R. Coleman, Y. Reiter, and K. Skorecki The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res., April 1, 2006; 66(7): 3792 - 3801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Kadkol, A. Y. Lin, V. Barak, I. Kalickman, L. Leach, K. Valyi-Nagy, D. Majumdar, S. Setty, A. J. Maniotis, R. Folberg, et al. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 802 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Girnita, C. All-Ericsson, M. A. Economou, K. Astrom, M. Axelson, S. Seregard, O. Larsson, and L. Girnita The Insulin-Like Growth Factor-I Receptor Inhibitor Picropodophyllin Causes Tumor Regression and Attenuates Mechanisms Involved in Invasion of Uveal Melanoma Cells Clin. Cancer Res., February 15, 2006; 12(4): 1383 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakahara, S. M. Norberg, D. R. Shalinsky, D. D. Hu-Lowe, and D. M. McDonald Effect of Inhibition of Vascular Endothelial Growth Factor Signaling on Distribution of Extravasated Antibodies in Tumors Cancer Res., February 1, 2006; 66(3): 1434 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Braun and A. Abbas Orthotopic Human Choroidal Melanoma Xenografts in Nude Rats with Aggressive and Nonaggressive PAS Staining Patterns Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W.J. van der Schaft, F. Hillen, P. Pauwels, D. A. Kirschmann, K. Castermans, M. G.A. oude Egbrink, M. G.B. Tran, R. Sciot, E. Hauben, P. C.W. Hogendoorn, et al. Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia Cancer Res., December 15, 2005; 65(24): 11520 - 11528. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Fathers, C. M. Stone, K. Minhas, J. J.A. Marriott, J. D. Greenwood, D. J. Dumont, and B. L. Coomber Heterogeneity of Tie2 Expression in Tumor Microcirculation: Influence of Cancer Type, Implantation Site, and Response to Therapy Am. J. Pathol., December 1, 2005; 167(6): 1753 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Seftor, K. M. Brown, L. Chin, D. A. Kirschmann, W. W. Wheaton, A. Protopopov, B. Feng, Y. Balagurunathan, J. M. Trent, B. J. Nickoloff, et al. Epigenetic Transdifferentiation of Normal Melanocytes by a Metastatic Melanoma Microenvironment Cancer Res., November 15, 2005; 65(22): 10164 - 10169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clarijs, M. van Dijk, D. J. Ruiter, and R. M. W. de Waal Functional and Morphologic Analysis of the Fluid-Conducting Meshwork in Xenografted Cutaneous and Primary Uveal Melanoma Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3013 - 3020. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Larrivee, K. Niessen, I. Pollet, S. Y. Corbel, M. Long, F. M. Rossi, P. L. Olive, and A. Karsan Minimal Contribution of Marrow-Derived Endothelial Precursors to Tumor Vasculature J. Immunol., September 1, 2005; 175(5): 2890 - 2899. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Yue and Z.-P. Chen Does Vasculogenic Mimicry Exist in Astrocytoma? J. Histochem. Cytochem., August 1, 2005; 53(8): 997 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Notting, J. T. Buijs, I. Que, R. E. Mintardjo, G. van der Horst, M. Karperien, G. S. O. A. Missotten, N. E. Schalij-Delfos, J. E. E. Keunen, and G. van der Pluijm Whole-Body Bioluminescent Imaging of Human Uveal Melanoma in a New Mouse Model of Local Tumor Growth and Metastasis Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1581 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Stein Mechanogenomic Control of DNA Exposure and Sequestration Am. J. Pathol., April 1, 2005; 166(4): 959 - 962. [Full Text] [PDF] |
||||
![]() |
A. J. Maniotis, K. Valyi-Nagy, J. Karavitis, J. Moses, V. Boddipali, Y. Wang, R. Nunez, S. Setty, Z. Arbieva, M. J. Bissell, et al. Chromatin Organization Measured by AluI Restriction Enzyme Changes with Malignancy and Is Regulated by the Extracellular Matrix and the Cytoskeleton Am. J. Pathol., April 1, 2005; 166(4): 1187 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salerno, D. Palmieri, A. Bouadis, D. Halverson, and P. S. Steeg Nm23-H1 Metastasis Suppressor Expression Level Influences the Binding Properties, Stability, and Function of the Kinase Suppressor of Ras1 (KSR1) Erk Scaffold in Breast Carcinoma Cells Mol. Cell. Biol., February 15, 2005; 25(4): 1379 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. J. van der Schaft, R. E. B. Seftor, E. A. Seftor, A. R. Hess, L. M. Gruman, D. A. Kirschmann, Y. Yokoyama, A. W. Griffioen, and M. J. C. Hendrix Effects of Angiogenesis Inhibitors on Vascular Network Formation by Human Endothelial and Melanoma Cells J Natl Cancer Inst, October 6, 2004; 96(19): 1473 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lugassy, H. K. Kleinman, J. A. Engbring, D. R. Welch, J. F. Harms, R. Rufner, G. Ghanem, S. R. Patierno, and R. L. Barnhill Pericyte-Like Location of GFP-Tagged Melanoma Cells: Ex Vivo and In Vivo Studies of Extravascular Migratory Metastasis Am. J. Pathol., April 1, 2004; 164(4): 1191 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Baluk, S. Morikawa, A. Haskell, M. Mancuso, and D. M. McDonald Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors Am. J. Pathol., November 1, 2003; 163(5): 1801 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ruf, E. A. Seftor, R. J. Petrovan, R. M. Weiss, L. M. Gruman, N. V. Margaryan, R. E. B. Seftor, Y. Miyagi, and M. J. C. Hendrix Differential Role of Tissue Factor Pathway Inhibitors 1 and 2 in Melanoma Vasculogenic Mimicry Cancer Res., September 1, 2003; 63(17): 5381 - 5389. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hess, E. A. Seftor, R. E. B. Seftor, and M. J. C. Hendrix Phosphoinositide 3-Kinase Regulates Membrane Type 1-Matrix Metalloproteinase (MMP) and MMP-2 Activity during Melanoma Cell Vasculogenic Mimicry Cancer Res., August 15, 2003; 63(16): 4757 - 4762. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, Z. Ai, M. Rasmussen, P. Bajcsy, L. Auvil, M. Welge, L. Leach, S. Vangveeravong, A. J. Maniotis, and R. Folberg Three-Dimensional Reconstruction of Extravascular Matrix Patterns and Blood Vessels in Human Uveal Melanoma Tissue: Techniques and Preliminary Findings Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2834 - 2840. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Cheng, M. Abdel-Ghany, and B. U. Pauli A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis J. Biol. Chem., June 27, 2003; 278(27): 24600 - 24607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.'a T. Al-Jamal, T. Makitie, and T. Kivela Nucleolar Diameter and Microvascular Factors as Independent Predictors of Mortality from Malignant Melanoma of the Choroid and Ciliary Body Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2381 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Klisovic, S. E. Katz, D. Effron, M. I. Klisovic, J. Wickham, M. R. Parthun, M. Guimond, and G. Marcucci Depsipeptide (FR901228) Inhibits Proliferation and Induces Apoptosis in Primary and Metastatic Human Uveal Melanoma Cell Lines Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2390 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Garattini New approaches to cancer therapy Ann. Onc., June 1, 2003; 14(6): 813 - 816. [Full Text] [PDF] |
||||
![]() |
S. M. Rybak, E. Sanovich, M. G. Hollingshead, S. D. Borgel, D. L. Newton, G. Melillo, D. Kong, G. Kaur, and E. A. Sausville "Vasocrine" Formation of Tumor Cell-lined Vascular Spaces: Implications for Rational Design of Antiangiogenic Therapies Cancer Res., June 1, 2003; 63(11): 2812 - 2819. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. C. M. Smetsers, E. M. A. van de Westerlo, G. B. ten Dam, R. Clarijs, E. M. M. Versteeg, W. L. van Geloof, J. H. Veerkamp, G. N. P. van Muijen, and T. H. van Kuppevelt Localization and Characterization of Melanoma-associated Glycosaminoglycans: Differential Expression of Chondroitin and Heparan Sulfate Epitopes in Melanoma Cancer Res., June 1, 2003; 63(11): 2965 - 2970. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clarijs, L. Schalkwijk, D. J. Ruiter, and R. M. W. de Waal EMAP-II Expression Is Associated with Macrophage Accumulation in Primary Uveal Melanoma Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1801 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mareel and A. Leroy Clinical, Cellular, and Molecular Aspects of Cancer Invasion Physiol Rev, April 1, 2003; 83(2): 337 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Walker-Daniels, A. R. Hess, M. J.C. Hendrix, and M. S. Kinch Differential Regulation of EphA2 in Normal and Malignant Cells Am. J. Pathol., April 1, 2003; 162(4): 1037 - 1042. [Full Text] [PDF] |
||||
![]() |
L. Righi, S. Deaglio, C. Pecchioni, A. Gregorini, A. L. Horenstein, G. Bussolati, A. Sapino, and F. Malavasi Role of CD31/Platelet Endothelial Cell Adhesion Molecule-1 Expression in in Vitro and in Vivo Growth and Differentiation of Human Breast Cancer Cells Am. J. Pathol., April 1, 2003; 162(4): 1163 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Walker, P. R. van Ginkel, R. L. Gee, H. Ahmadi, L. Subramanian, B. R. Ksander, L. F. Meisner, D. M. Albert, and A. S. Polans Expression of Angiogenic Factors Cyr61 and Tissue Factor in Uveal Melanoma Arch Ophthalmol, December 1, 2002; 120(12): 1719 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Lee, N. Nagai, C.-H. Siar, K. Nakano, H. Nagatsuka, H. Tsujigiwa, C.-H. Roan, and M. Gunduz Angioarchitecture of Primary Oral Malignant Melanomas J. Histochem. Cytochem., November 1, 2002; 50(11): 1555 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tei, N. Kawakami-Kimura, O. Taguchi, K. Kumamoto, S. Higashiyama, N. Taniguchi, K.'i. Toda, R. Kawata, Y. Hisa, and R. Kannagi Roles of Cell Adhesion Molecules in Tumor Angiogenesis Induced by Cotransplantation of Cancer and Endothelial Cells to Nude Rats Cancer Res., November 1, 2002; 62(21): 6289 - 6296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herlyn, M. Padarathsingh, L. Chin, M. Hendrix, D. Becker, M. Nelson, Y. DeClerck, J. McCarthy, and S. Mohla New Approaches to the Biology of Melanoma: A Workshop of the National Institutes of Health Pathology B Study Section Am. J. Pathol., November 1, 2002; 161(5): 1949 - 1957. [Full Text] [PDF] |
||||
![]() |
R. E. B. Seftor, E. A. Seftor, D. A. Kirschmann, and M. J. C. Hendrix Targeting the Tumor Microenvironment with Chemically Modified Tetracyclines: Inhibition of Laminin 5 {gamma}2 Chain Promigratory Fragments and Vasculogenic Mimicry Mol. Cancer Ther., November 1, 2002; 1(13): 1173 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu, H. Huang, F. Donate, C. Dickinson, R. Santucci, A. El-Sheikh, R. Vessella, and T. S. Edgington Prostate-specific Membrane Antigen Directed Selective Thrombotic Infarction of Tumors Cancer Res., October 1, 2002; 62(19): 5470 - 5475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Favier, P.-F. Plouin, P. Corvol, and J.-M. Gasc Angiogenesis and Vascular Architecture in Pheochromocytomas : Distinctive Traits in Malignant Tumors Am. J. Pathol., October 1, 2002; 161(4): 1235 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Scappaticci Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies J. Clin. Oncol., September 15, 2002; 20(18): 3906 - 3927. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Braun, A. Abbas, S. O. Bukhari, and W. Wilson III Hemodynamic Parameters in Blood Vessels in Choroidal Melanoma Xenografts and Rat Choroid Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3045 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Zamboni, A. C. Gervais, M. J. Egorin, J. H. M. Schellens, D. R. Hamburger, B. J. Delauter, A. Grim, E. G. Zuhowski, E. Joseph, D. Pluim, et al. Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin Clin. Cancer Res., September 1, 2002; 8(9): 2992 - 2999. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jessani, Y. Liu, M. Humphrey, and B. F. Cravatt Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness PNAS, August 6, 2002; 99(16): 10335 - 10340. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, A. J. Maniotis, D. Majumdar, J. Pe'er, and R. Folberg Uveal Melanoma Cell Staining for CD34 and Assessment of Tumor Vascularity Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2533 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Wang, J. Zhou, K. Zhu, A. I. Riker, F. M. Marincola, and R.-F. Wang Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells: Its Role in Extracellular Matrix Formation and Tumor Metastasis J. Exp. Med., June 3, 2002; 195(11): 1397 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. L. Woodward, C. E. Nichols, I. G. Rennie, M. A. Parsons, A. K. Murray, and K. Sisley An In Vitro Assay to Assess Uveal Melanoma Invasion across Endothelial and Basement Membrane Barriers Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1708 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thies, I. Moll, J. Berger, C. Wagener, J. Brummer, H.-J. Schulze, G. Brunner, and U. Schumacher CEACAM1 Expression in Cutaneous Malignant Melanoma Predicts the Development of Metastatic Disease J. Clin. Oncol., May 15, 2002; 20(10): 2530 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Carles-Kinch, K. E. Kilpatrick, J. C. Stewart, and M. S. Kinch Antibody Targeting of the EphA2 Tyrosine Kinase Inhibits Malignant Cell Behavior Cancer Res., May 1, 2002; 62(10): 2840 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clarijs, I. Otte-Holler, D. J. Ruiter, and R. M. W. de Waal Presence of a Fluid-Conducting Meshwork in Xenografted Cutaneous and Primary Human Uveal Melanoma Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 912 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Straume and L. A. Akslen Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression Am. J. Pathol., March 1, 2002; 160(3): 1009 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. C. Hendrix, R. E. B. Seftor, E. A. Seftor, L. M. Gruman, L. M. L. Lee, B. J. Nickoloff, L. Miele, D. D. Sheriff, and G. C. Schatteman Transendothelial Function of Human Metastatic Melanoma Cells: Role of the Microenvironment in Cell-Fate Determination Cancer Res., February 1, 2002; 62(3): 665 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, K. Shirakawa, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, I. Watanabe, Y. Heike, K. Togashi, J. Konishi, et al. Rapid Accumulation and Internalization of Radiolabeled Herceptin in an Inflammatory Breast Cancer Xenograft with Vasculogenic Mimicry Predicted by the Contrast-enhanced Dynamic MRI with the Macromolecular Contrast Agent G6-(1B4M-Gd)256 Cancer Res., February 1, 2002; 62(3): 860 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dai, D. M. Wolf, E. S. Litman, M. J. White, and K. K. Leslie Progesterone Inhibits Human Endometrial Cancer Cell Growth and Invasiveness: Down-Regulation of Cellular Adhesion Molecules through Progesterone B Receptors Cancer Res., February 1, 2002; 62(3): 881 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sood, M. S. Fletcher, and M. J. C. Hendrix The Embryonic-Like Properties of Aggressive Human Tumor Cells Reproductive Sciences, January 1, 2002; 9(1): 2 - 9. [Abstract] [PDF] |
||||
![]() |
K. Shirakawa, H. Kobayashi, Y. Heike, S. Kawamoto, M. W. Brechbiel, F. Kasumi, T. Iwanaga, F. Konishi, M. Terada, and H. Wakasugi Hemodynamics in Vasculogenic Mimicry and Angiogenesis of Inflammatory Breast Cancer Xenograft Cancer Res., January 1, 2002; 62(2): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Longo, M. Yanez-Mo, M. Mittelbrunn, G. de la Rosa, M.-L. Munoz, F. Sanchez-Madrid, and P. Sanchez-Mateos Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells Blood, December 15, 2001; 98(13): 3717 - 3726. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Zantek, J. Walker-Daniels, J. Stewart, R. K. Hansen, D. Robinson, H. Miao, B. Wang, H.-J. Kung, M. J. Bissell, and M. S. Kinch MCF-10A-NeoST: A New Cell System for Studying Cell-ECM and Cell-Cell Interactions in Breast Cancer Clin. Cancer Res., November 1, 2001; 7(11): 3640 - 3648. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Makitie, O. Carpen, A. Vaheri, and T. Kivela Ezrin as a Prognostic Indicator and Its Relationship to Tumor Characteristics in Uveal Malignant Melanoma Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2442 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. M. Scholes, T. Liloglou, P. Maloney, S. Hagan, J. Nunn, P. Hiscott, B. E. Damato, I. Grierson, and J. K. Field Loss of Heterozygosity on Chromosomes 3, 9, 13, and 17, Including the Retinoblastoma Locus, in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2472 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Graeven, U. Rodeck, S. Karpinski, M. Jost, S. Philippou, and W. Schmiegel Modulation of Angiogenesis and Tumorigenicity of Human Melanocytic Cells by Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Cancer Res., October 1, 2001; 61(19): 7282 - 7290. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. B. Seftor, E. A. Seftor, N. Koshikawa, P. S. Meltzer, L. M. G. Gardner, M. Bilban, W. G. Stetler-Stevenson, V. Quaranta, and M. J. C. Hendrix Cooperative Interactions of Laminin 5 {gamma}2 Chain, Matrix Metalloproteinase-2, and Membrane Type-1-Matrix/Metalloproteinase Are Required for Mimicry of Embryonic Vasculogenesis by Aggressive Melanoma Cancer Res., September 1, 2001; 61(17): 6322 - 6327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Nam, T. Clair, Y.-S. Kim, A. McMarlin, E. Schiffmann, L. A. Liotta, and M. L. Stracke Autotaxin (NPP-2), a Metastasis-enhancing Motogen, Is an Angiogenic Factor Cancer Res., September 1, 2001; 61(18): 6938 - 6944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kashani-Sabet, R. W. Sagebiel, C. M. M. Ferreira, M. Nosrati, and J. R. Miller III Vascular Involvement in the Prognosis of Primary Cutaneous Melanoma Arch Dermatol, September 1, 2001; 137(9): 1169 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kivela, S. Eskelin, T. Makitie, and P. Summanen Exudative Retinal Detachment from Malignant Uveal Melanoma: Predictors and Prognostic Significance Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2085 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Harraz, C. Jiao, H. D. Hanlon, R. S. Hartley, and G. C. Schatteman CD34- Blood-Derived Human Endothelial Cell Progenitors Stem Cells, July 1, 2001; 19(4): 304 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Straume and L. A. Akslen Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas Am. J. Pathol., July 1, 2001; 159(1): 223 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. C. Hendrix, E. A. Seftor, P. S. Meltzer, L. M. G. Gardner, A. R. Hess, D. A. Kirschmann, G. C. Schatteman, and R. E. B. Seftor Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry PNAS, June 12, 2001; (2001) 131209798. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mäkitie, P. Summanen, A. Tarkkanen, and T. Kivelä Tumor-Infiltrating Macrophages (CD68+ Cells) and Prognosis in Malignant Uveal Melanoma Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1414 - 1421. [Abstract] [Full Text] |
||||
![]() |
R. Clarijs, L. Schalkwijk, D. J. Ruiter, and R. M. W. de Waal Lack of Lymphangiogenesis Despite Coexpression of VEGF-C and Its Receptor Flt-4 in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1422 - 1428. [Abstract] [Full Text] |
||||
![]() |
C. Khanna, J. Khan, P. Nguyen, J. Prehn, J. Caylor, C. Yeung, J. Trepel, P. Meltzer, and L. Helman Metastasis-associated Differences in Gene Expression in a Murine Model of Osteosarcoma Cancer Res., May 1, 2001; 61(9): 3750 - 3759. [Abstract] [Full Text] |
||||
![]() |
The Collaborative Ocular Melanoma Study Group Assessment of Metastatic Disease Status at Death in 435 Patients With Large Choroidal Melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS Report No. 15 Arch Ophthalmol, May 1, 2001; 119(5): 670 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hess, E. A. Seftor, L. M. G. Gardner, K. Carles-Kinch, G. B. Schneider, R. E. B. Seftor, M. S. Kinch, and M. J. C. Hendrix Molecular Regulation of Tumor Cell Vasculogenic Mimicry by Tyrosine Phosphorylation: Role of Epithelial Cell Kinase (Eck/EphA2) Cancer Res., April 1, 2001; 61(8): 3250 - 3255. [Abstract] [Full Text] |
||||
![]() |
A. K. Sood, E. A. Seftor, M. S. Fletcher, L. M. G. Gardner, P. M. Heidger, R. E. Buller, R. E. B. Seftor, and M. J. C. Hendrix Molecular Determinants of Ovarian Cancer Plasticity Am. J. Pathol., April 1, 2001; 158(4): 1279 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. M. Scholes, S. Hagan, P. Hiscott, B. E. Damato, and I. Grierson Overexpression of Epidermal Growth Factor Receptor Restricted to Macrophages in Uveal Melanoma Arch Ophthalmol, March 1, 2001; 119(3): 373 - 377. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |